135 results on '"Batista, Alzir A."'
Search Results
2. New Ru(Ii)-P-Cymene Compounds Bearing Indomethacin and Indomethacin-Pyridineamide Ligands: Synthesis, Characterization, Computational Studies and Investigation of Their Interactions with the Human Serum Albumin
3. Cobalt(III)-py2en systems as potential carriers of β-ketoester-based ligands
4. An overview on the anticancer activity of Ru(II)/acylthiourea complexes
5. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos -[(2-diphenylphosphino)phenyl]ether)
6. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
7. Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis
8. Cobalt(III)-py 2en Systems as Potential Carriers of β-Ketoester-Based Ligands
9. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway
10. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents
11. Cytotoxic and antiparasitic activities of diphosphine-metal complexes of group 10 containing acylthiourea as ligands
12. Gold(III) heteroleptic complexes with SNS-thiosemicarbazonate ligands as cytotoxic agents: Experimental and computational insights into the mechanism of action
13. Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis
14. Gold(Iii) Heteroleptic Complexes with Sns-Thiosemicarbazonate Ligands as Cytotoxic Agents: Experimental and Computational Insights into the Mechanism of Action
15. Gallium and Indium Complexes with Isoniazid-Derived Ligands: Interaction with Biomolecules and Biological Activity Against Cancer Cells and Mycobacterium Tuberculosis
16. Cytotoxic and Antiparasitic Activities of Diphosphine-Metal Complexes of Group 10 Containing Acylthiourea as Ligands
17. Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand
18. Scavenging capacity and cytotoxicity of new Ru(II)-diphosphine/α-amino acid complexes
19. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies
20. Synthesis and characterization of η6-p-cymene ruthenium(II) complexes containing alkyl- and methoxy-substituted triarylphosphines
21. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug
22. Cytotoxicity of ruthenium-N,N-disubstituted-N′-acylthioureas complexes
23. Antitumor activity of Pd(II) complexes with N,S or O,S coordination modes of acylthiourea ligands
24. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid
25. Ruthenium (II) complexes with N, O-chelating proline and threonine ligands cause selective cytotoxicity by the induction of genomic instability, cell cycle arrest and apoptosis in breast and prostate tumor cells
26. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
27. cis-bis(N-benzoyl-N′,N′-dibenzylthioureido)platinum(II): Synthesis, molecular structure and its interaction with human and bovine serum albumin
28. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
29. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
30. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
31. A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands
32. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells
33. Carbonyl–heterobimetallic Ru(II)/Fe(II)–complexes containing polypyridyl ligands: Synthesis, characterization, cellular viability assays and interactions with biomolecules
34. Acute toxic effects of ruthenium (II)/amino acid/diphosphine complexes on Swiss mice and zebrafish embryos
35. The trans -[Ru(PPh 3 ) 2 ( N , N -dimethyl- N ′-thiophenylthioureato-k 2 O,S)(bipy)]PF 6 complex has pro-apoptotic effects on triple negative breast cancer cells and presents low toxicity in vivo
36. Hydrolysis reaction promotes changes in coordination mode of Ru(II)/acylthiourea organometallic complexes with cytotoxicity against human lung tumor cell lines
37. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
38. Phosphine/diimine ruthenium complexes with Cl−, CO, NO+, NO2−, NO3− and pyridine ligands: Pro-apoptotic activity on triple-negative breast cancer cells and DNA/HSA interactions
39. cis -[RuCl(BzCN)(bipy)(dppe)]PF6 induces anti-angiogenesis and apoptosis by a mechanism of caspase-dependent involving DNA damage, PARP activation, and Tp53 induction in Ehrlich tumor cells
40. Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis
41. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
42. Palladium(II)/ N , N -disubstituted- N ′-acylthioureas complexes as anti- Mycobacterium tuberculosis and anti- Trypanosoma cruzi agents
43. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
44. Antitumor and anti-Mycobacterium tuberculosis agents based on cationic ruthenium complexes with amino acids
45. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
46. Heteroleptic tris-chelate ruthenium(II) complexes of N,N-disubstituted-N′-acylthioureas: Synthesis, structural studies, cytotoxic activity and confocal microscopy studies
47. Understanding the conformational changes and molecular structure of furoyl thioureas upon substitution
48. Hydroformylation-hydrogenation and hydroformylation-acetalization reactions catalyzed by ruthenium complexes
49. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF6[dppb = 1,4-bis(diphenylphosphine)butane and bipy = 2,2′-bipyridine]
50. Experimental and theoretical studies of copper complexes with isomeric dipeptides as novel candidates against breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.